Injectable Drug Delivery Resources

1. Vial Containment Systems For Gene And Cell Therapies 5/24/2024

   CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.

2. Reasons Blow/Fill/Seal Technology Should Be Considered For Aseptic Filling

   Drug manufacturers seeking alternative methods for a safe and reliable approach to drug delivery should consider blow-fill-seal technology, as it offers several benefits over traditional glass packaging.

3. Lyophilization vs. Liquid Formation: Why Lyo Offers Advantages 3/8/2022

   Lyophilization offers some alluring advantages in today’s complex market, but its challenges require innovation and expertise to surmount.

4. Steps To Overcome Challenges Associated With Biologic Formulation Development 8/24/2022

   Explore guidance on the challenges posed by biologics, including overcoming degradation, establishing a stress test process, and the value of lipid nanoparticles (LNPs) and polymeric nanoparticles (NPs).

5. Supporting The Unique Needs Of Your Sterile Injectable

   Leveraging the experience and specialized technology of a reliable CDMO partner is essential to ensure your sterile injectable therapeutic's safety and quality while delivering at speed.

6. Addressing Glass Particulates In Injectable Drug Formulations

   Learn how a new vial design that is capable of reducing the propensity for glass particulate generation on filling lines is enabling a significant, positive impact on product quality and safety.

7. Aseptic Filling And Processing Considerations For Biosimilars 10/11/2023

   One of the most intriguing, high-stakes aspects of R&D is the realm of biosimilars. Explore the challenges of biosimilar production as well as aseptic processing considerations for biosimilars.

8. Computational Modeling Of Injection-Related Tissue Responses 6/15/2022

   Optimizing delivery along with the formulation is the key to successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length.

9. Mitigating Particulate Risk In Injectables

   What are the sources of such particulates in injectables, and how should manufacturers apply the latest regulations to ensure best practice when producing sterile drug products?

10. Avoiding The Pitfalls Of LNPs And Complex Formulations

    Explore the necessary components of a smooth tech transfer for LNP-based drugs, including the variables that impact LNP formulation and the outsourcing strategies needed to avoid common pitfalls.